PMID- 28833102 OWN - NLM STAT- MEDLINE DCOM- 20181211 LR - 20190401 IS - 1097-4652 (Electronic) IS - 0021-9541 (Print) IS - 0021-9541 (Linking) VI - 233 IP - 4 DP - 2018 Apr TI - Tetrahydrocurcumin ameliorates homocysteine-mediated mitochondrial remodeling in brain endothelial cells. PG - 3080-3092 LID - 10.1002/jcp.26145 [doi] AB - Homocysteine (Hcy) causes endothelial dysfunction by inducing oxidative stress in most neurodegenerative disorders. This dysfunction is highly correlated with mitochondrial dynamics such as fusion and fission. However, there are no strategies to prevent Hcy-induced mitochondrial remodeling. Tetrahydrocurcumin (THC) is an anti-inflammatory and anti-oxidant compound. We hypothesized that THC may ameliorates Hcy-induced mitochondria remodeling in mouse brain endothelial cells (bEnd3) cells. bEnd3 cells were exposed to Hcy treatment in the presence or absence of THC. Cell viability and autophagic cell death were measured with MTT and MDC staining assay. Reactive oxygen species (ROS) production was determined using DCFH-DA staining by confocal microscopy. Autophagy flux was assessed using a conventional GFP-microtubule-associated protein 1 light chain 3 (LC3) dot assay. Interaction of phagophore marker LC-3 with mitochondrial receptor NIX was observed by confocal imaging. Mitochondrial fusion and fission were evaluated by western blot and RT-PCR. Our results demonstrated that Hcy resulted in cell toxicity in a dose-dependent manner and supplementation of THC prevented the detrimental effects of Hcy on cell survival. Furthermore, Hcy also upregulated fission marker (DRP-1), fusion marker (Mfn2), and autophagy marker (LC-3). Finally, we observed that Hcy activated mitochondrial specific phagophore marker (LC-3) and co-localized with the mitochondrial receptor NIX, as viewed by confocal microscopy. Pretreatment of bEnd3 with THC (15 muM) ameliorated Hcy-induced oxidative damage, mitochondrial fission/fusion, and mitophagy. Our studies strongly suggest that THC has beneficial effects on mitochondrial remodeling and could be developed as a potential therapeutic agent against hyperhomocysteinemia (HHcy) induced mitochondrial dysfunction. CI - (c) 2017 Wiley Periodicals, Inc. FAU - Vacek, Jonathan C AU - Vacek JC AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. FAU - Behera, Jyotirmaya AU - Behera J AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. FAU - George, Akash K AU - George AK AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. FAU - Kamat, Pradip K AU - Kamat PK AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. FAU - Kalani, Anuradha AU - Kalani A AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. FAU - Tyagi, Neetu AU - Tyagi N AUID- ORCID: 0000-0003-0285-5072 AD - Department of Physiology, School of Medicine, Health Sciences Center, University of Louisville, Louisville, Kentucky. LA - eng GR - R01 AR067667/AR/NIAMS NIH HHS/United States GR - R01 HL107640/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20171114 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Mitochondrial Proteins) RN - 0 (Reactive Oxygen Species) RN - 00U0645U03 (tetrahydrocurcumin) RN - 0LVT1QZ0BA (Homocysteine) RN - IT942ZTH98 (Curcumin) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Autophagy/drug effects MH - Brain MH - Cell Survival/drug effects MH - Cells, Cultured MH - Curcumin/*analogs & derivatives/pharmacology MH - Cytoprotection/drug effects MH - Endothelial Cells/drug effects/*metabolism MH - Gene Expression Regulation/drug effects MH - Homocysteine/*toxicity MH - Intracellular Space/metabolism MH - Mice MH - Mitochondria/drug effects/*metabolism MH - Mitochondrial Dynamics/drug effects MH - Mitochondrial Proteins/metabolism MH - Models, Biological MH - Reactive Oxygen Species/metabolism PMC - PMC6035784 MID - NIHMS903889 OTO - NOTNLM OT - apoptosis OT - autophagy OT - curcumin OT - mitochondria biogenesis OT - reactive oxygen species COIS- Conflict of Interest: Authors have declared no conflict of interest. EDAT- 2017/08/24 06:00 MHDA- 2018/12/12 06:00 PMCR- 2019/04/01 CRDT- 2017/08/24 06:00 PHST- 2016/11/08 00:00 [received] PHST- 2017/08/08 00:00 [accepted] PHST- 2017/08/24 06:00 [pubmed] PHST- 2018/12/12 06:00 [medline] PHST- 2017/08/24 06:00 [entrez] PHST- 2019/04/01 00:00 [pmc-release] AID - 10.1002/jcp.26145 [doi] PST - ppublish SO - J Cell Physiol. 2018 Apr;233(4):3080-3092. doi: 10.1002/jcp.26145. Epub 2017 Nov 14.